Kaplan–Meier analysis showed that patients with higher SNX29 levels had shorter OS in BLCA (p = 0.0052), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC) (p = 0.0208), lung squamous cell carcinoma (LUSC) (p = 0.017), skin cutaneous melanoma (SKCM) (p = 0.0422), and STAD (p = 0.0467) (Fig. 2E–I). This evidence concerns the gene SNX29 and diffuse large B-cell lymphoma.